ADVA Biotechnology founder explains disruptive medical technologyADVA has developed solutions to enable manufacturing for personalized cell therapy for specific patients at bedside.ADVA Biotechnology founder and CEO Dr. Ohad Karnieli is seen addressing The Jerusalem Post Annual Conference.(photo credit: LIOR LEV)
